IL6 and chronic graft versus host disease: The IL-6 responsiveness to classical and IL-6-trans-signaling of CD3+CD4+ and CD3+CD8+ T cells on day +90 post-transplant showed no association with later development of chronic GVHD requiring immunosuppressive therapy one year post-transplant (data not shown).